Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v36-FR Version v10-FR
Language French French
Date Updated 2018-10-03 2017-08-10
Drug Identification Number 02390019 02390019
Brand name ONDANSETRON INJECTION, USP ONDANSETRON INJECTION, USP
Common or Proper name ONDANSETRON INJECTION, USP ONDANSETRON INJECTION, USP
Company Name MYLAN PHARMACEUTICALS ULC MYLAN PHARMACEUTICALS ULC
Ingredients ONDANSETRON ONDANSETRON
Strength(s) 2MG 2MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 4ML 5VL, 2ML 5VL 4ML 5VL
ATC code A04AA A04AA
ATC description ANTIEMETICS AND ANTINAUSEANTS ANTIEMETICS AND ANTINAUSEANTS
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2017-09-30
Actual start date 2018-09-17
Estimated end date 2018-10-12 2018-01-12
Actual end date
Shortage status Actual shortage Anticipated shortage
Tier 3 Status No No
Company comments
Health Canada comments